Global GIL Recognition Spotlights Apeloa’s End-to-End “API + Drug Product” Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated MarketsSHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) — Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven…

Read More

Editor' Pick

Canada News

Lifestyle

Tech & Innovation

Latest News